Clinical Trial Update: Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer

View source ↗

Summary

Clinical trial update on the therapeutic and prognostic impact of circulating tumor cells in peripheral blood of patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: National Institute of Cancerología | Conditions: Circulating Tumor Cells | Status: UNKNOWN